Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2025-12-26 @ 5:41 PM
Study NCT ID:
NCT01719003
Status:
COMPLETED
Last Update Posted:
2016-02-19
First Post:
2012-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2014-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-30
First Submit QC Date:
None
Study First Post Date:
2012-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-23
Results First Submit QC Date:
None
Results First Post Date:
2016-02-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-22
Last Update Post Date:
2016-02-19
Last Update Post Date Type:
ESTIMATED